Mannose Receptor: Regulating Blood Proteins – New Strategy Revealed
Unlocking the Secrets of Blood Plasma: How a Single Protein Influences Health and Disease
Table of Contents
Key Protein Mrc1’s Role in Maintaining Blood Plasma balance Revealed
Sanford Burnham Prebys,CA – Researchers have identified a crucial protein,Mrc1,that plays a vital role in maintaining the delicate balance of proteins in blood plasma. A recent study published in Nature Communications reveals that Mrc1’s absence leads to a significant accumulation of specific proteins, impacting various bodily functions and potentially contributing to age-related diseases and conditions like sepsis.
Mrc1: The Gatekeeper of Blood Plasma Proteins
Mrc1, also known as Mannose Receptor C-type 1, acts as a critical regulator, keeping the concentration of numerous essential blood plasma proteins within a healthy range. Its primary mechanism involves binding to proteins modified with mannose, often referred to as mannosylated proteins. This binding triggers an endocytic clearance process, effectively limiting the lifespan and abundance of these proteins in circulation.
“Comparisons revealed an increased sensitivity and selectivity allowing identification of the receptor’s ligands as they accumulate in the blood in the absence of Mrc1,” stated Saraswat.
The Impact of Mrc1 deficiency
To understand Mrc1’s function, scientists compared blood samples from normal mice and mice genetically engineered to lack Mrc1. The findings were striking: the absence of Mrc1 resulted in the accumulation of 244 mannosylated blood plasma proteins, with their levels doubling or more compared to normal mice. This accumulation is a direct consequence of Mrc1 no longer being present to regulate their clearance.
Unveiling the Function of accumulated Proteins
The research team then delved deeper into the identities of these newly identified accumulated proteins, utilizing bioinformatics to analyze their functions. This analysis revealed that many of these proteins play significant roles in the body’s vital systems.
“We noticed that a lot of the proteins had very vital roles to play. Renin and angiotensin converting enzyme, for example, are major regulators of blood pressure,” explained Jamey Marth, PhD, professor at Sanford Burnham Prebys and senior and corresponding author of the manuscript.
Further examination focused on eight specific proteins known to influence blood pressure, inflammation, organ function, and sepsis.The researchers observed a disruption in normal physiological processes,directly correlating with the identities of the accumulating mannosylated proteins. This disruption was also found to worsen with chronological age.
Mrc1’s Role in Sepsis and Disease Progression
The study highlighted Mrc1’s critical role in the context of sepsis. Mice lacking Mrc1 succumbed to the condition more rapidly than their normal counterparts. While initial comparisons of blood samples from human sepsis patients and Mrc1-deficient mice showed differences in the specific accumulating proteins,a significant overlap was found in the pathways affected.
“When we looked at samples of blood from human sepsis patients, we found that there was a difference in the proteins that were accumulating when compared to the Mrc1-deficient mice,” said Saraswat. “However, when we compared the pathways controlled by these proteins, half of those activated in human sepsis were also activated by mrc-1 dysfunction.”
Future Directions: Deciphering the Glycosylation Language
The findings underscore the importance of understanding the complex interplay between glycosidic linkages, protein abundance, and activity in maintaining health.
“To understand the part that glycosidic linkages are playing in health and disease by modifying the abundance and activity of blood glycoproteins, we need to decipher this new language spanning protein glycosylation, detect abnormalities and determine how this system translates in the body to affect different physiological functions,” concluded Saraswat.
This research opens new avenues for understanding and potentially treating a range of conditions linked to dysregulated blood plasma protein levels, offering hope for improved diagnostics and therapies in the future.
Source:
Journal reference: Restagno, D., et al. (2025).Mrc1 (MMR, CD206) controls the blood proteome in reducing inflammation, age-associated organ dysfunction and mortality in sepsis. Nature Communications.doi.org/10.1038/s41467-025-61346-4.